Disease Models & Mechanisms (Mar 2023)
Autism-linked NLGN3 is a key regulator of gonadotropin-releasing hormone deficiency
- Roberto Oleari,
- Antonella Lettieri,
- Stefano Manzini,
- Alyssa Paganoni,
- Valentina André,
- Paolo Grazioli,
- Marco Busnelli,
- Paolo Duminuco,
- Antonio Vitobello,
- Christophe Philippe,
- Varoona Bizaoui,
- Helen L. Storr,
- Federica Amoruso,
- Fani Memi,
- Valeria Vezzoli,
- Valentina Massa,
- Peter Scheiffele,
- Sasha R. Howard,
- Anna Cariboni
Affiliations
- Roberto Oleari
- Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy
- Antonella Lettieri
- CRC Aldo Ravelli for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan 20142, Italy
- Stefano Manzini
- Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy
- Alyssa Paganoni
- Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy
- Valentina André
- Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy
- Paolo Grazioli
- Department of Health Sciences, University of Milan, Milan 20142, Italy
- Marco Busnelli
- Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy
- Paolo Duminuco
- Laboratory of Endocrine and Metabolic Research, IRCCS Istituto Auxologico Italiano, Cusano Milanino 20095, Italy
- Antonio Vitobello
- Unité Fonctionnelle Innovation en Diagnostic Génomique des Maladies Rares, Fédération Hospitalo-Universitaire (FHU) TRANSLAD, CHU Dijon Bourgogne, Dijon 21079, France
- Christophe Philippe
- Unité Fonctionnelle Innovation en Diagnostic Génomique des Maladies Rares, Fédération Hospitalo-Universitaire (FHU) TRANSLAD, CHU Dijon Bourgogne, Dijon 21079, France
- Varoona Bizaoui
- Genetics and Neurodevelopment, Centre Hospitalier de l'Estran, Pontorson 50170, France
- Helen L. Storr
- Centre for Endocrinology William Harvey Research Institute Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
- Federica Amoruso
- Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy
- Fani Memi
- Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge CB2 0AW, UK
- Valeria Vezzoli
- Laboratory of Endocrine and Metabolic Research, IRCCS Istituto Auxologico Italiano, Cusano Milanino 20095, Italy
- Valentina Massa
- CRC Aldo Ravelli for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan 20142, Italy
- Peter Scheiffele
- Biozentrum of the University of Basel, Basel 4056, Switzerland
- Sasha R. Howard
- Centre for Endocrinology William Harvey Research Institute Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
- Anna Cariboni
- Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy
- DOI
- https://doi.org/10.1242/dmm.049996
- Journal volume & issue
-
Vol. 16,
no. 3
Abstract
No abstracts available.Keywords